(Q37570459)

21 August 2017

A survey of the way pharmacokinetics are reported in published phase I clinical trials, with an emphasis on oncology (English)

1 reference

21 August 2017

phase I clinical trial

0 references

1 reference

Emmanuelle Comets

1

1 reference

21 August 2017

Sarah Zohar

series ordinal

2

1 reference

21 August 2017

1 January 2009

1 reference

Clinical Pharmacokinetics

21 August 2017

1 reference

21 August 2017

48

1 reference

21 August 2017

6

1 reference

21 August 2017

387-395

1 reference

Integrated pharmacokinetics and pharmacodynamics in drug development

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Impact of pharmacometrics on drug approval and labeling decisions: a survey of 42 new drug applications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Choice of designs and doses for early phase trials

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Estimating the starting dose for entry into humans: principles and practice

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Methodologic guidelines for the design of high-dose chemotherapy regimens

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Role of modelling and simulation in Phase I drug development

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Improving the quality of abstract reporting for phase I cancer trials

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Optimization of individual and population designs using Splus

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

Methodological Differences in Clinical Trials Evaluating Nonpharmacological and Pharmacological Treatments of Hip and Knee Osteoarthritis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2799636

10.2165/00003088-200948060-00004

3 December 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

0 references

1 reference

21 August 2017

PubMed publication ID

19650677

1 reference